v3.26.1
FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE (Tables)
 3 Months Ended
Mar. 31, 2026
Fair Value Disclosures [Abstract]  
Schedule of Financial Instruments Measured at Fair Value and their Levels in Fair Value Hierarchy The Company’s financial instruments measured at fair value and their respective levels in the fair value hierarchy as of March 31, 2026, and December 31, 2025, were as follows:

March 31, 2026December 31, 2025
Fair Value of LiabilitiesFair Value of Liabilities
In ThousandsLevel 1Level 2Level 3TotalLevel 1Level 2Level 3Total
Common warrants$— $— $89 $89 $— $— $79 $79 
Total$— $— $89 $89 $— $— $79 $79 
Schedule of Common Warrants Activity


The following table summarizes the common warrants activity for the three months ended March 31, 2026:

In ThousandsLevel 3 Fair Value of Liabilities
Balance as of December 31, 2025$79 
Change in fair value10 
Balance as of March 31, 2026$89 


The following table summarizes the common warrants activity for the three months ended March 31, 2025:

In ThousandsLevel 3 Fair Value of Liabilities
Balance as of December 31, 2024$2,268 
Reclassified to stockholders’ equity(1,589)
Change in fair value(462)
Balance as of March 31, 2025$217 
Schedule of Estimated Fair Values of Common Warrants, and Assumptions Used for Black-Scholes Option Pricing Model The estimated fair values of the common warrants, and the assumptions used for the Black-Scholes option pricing model were as follows:
 As of March 31, 2026As of December 31, 2025
Estimated fair value of common warrants per share
$0.02 - $0.86
$0.01 - $0.77
Assumptions: 
Risk-free interest rate
3.7% - 3.8%
3.4% - 3.6%
Expected volatility
113.6% - 114.5%
103.8% - 114.3%
Expected term to liquidation (in years)
1.4 - 3.2
1.6 - 3.5